Serum LACC1 level is a predictor of response to upadacitinib treatment in patients with rheumatoid arthritis: a prospective observational cohort study
Higher serum LACC1 levels are associated with better efficacy of UPA, with implications for optimizing clinical individualized dosing strategies.
Authors
- Shunquan Lin (ORCID: https://orcid.org/0000-0003-3190-6158)
- Yang Zhou (ORCID: https://orcid.org/0000-0001-7091-1051)
- Yuwei Zhan
Institutions
- Hainan General Hospital (CN)
- Hainan Medical University (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2025-08-20
- DOI
- https://doi.org/10.1186/s40001-025-02938-0
- Citations
- 2
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 3.34